<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[rna Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/rna.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to rna]]></description>
	<s:counts start="0" returned="20" found="138" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Affymetrix Q2 2009 Earnings Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14061_23-323781.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Our first question comes from the line of Marshall Urist with Morgan Stanley. Marshall Urist - Morgan Stanley Yeah, hey guys. Good afternoon. Kevin King Hey Marshall. Marshall Urist - Morgan Stanley A question on -- first question was just on the reagent rental program....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 22 Jul 2009 17:08:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/affymetrix.html"><![CDATA[Affymetrix]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AFFX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">AFFX,MS</category>
	</item>
	<item>
		<title><![CDATA[Affymetrix, Inc., Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14061_23-264690.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions And your first question comes from the line of Ross Muken. Ross Muken - Deutsche Bank North America  All right. Good afternoon, gentlemen. Kevin King Hi, Ross. Ross Muken - Deutsche Bank North America So, obviously, you talked a lot about some of the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 28 Jan 2009 17:05:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/deutsche+bank+ag.html"><![CDATA[Deutsche Bank AG]]></category>
		<category domain="http://resources.bnet.com/topic/product.html"><![CDATA[Product]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/affymetrix.html"><![CDATA[Affymetrix]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AFFX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DB</category>
		<category domain="tickers">AFFX,DB</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Isis Pharmaceuticals, Inc., Schering-Plough Corp., Sara Lee Corp., EnCana Corp. and Euroseas Ltd]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_24/ai_n28578472]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), Schering-Plough Corp. (NYSE: SGP), Sara Lee...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/encana+corp..html"><![CDATA[EnCana Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/isis+pharmaceuticals+inc..html"><![CDATA[Isis Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/sara+lee+corp..html"><![CDATA[Sara Lee Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ECA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SLE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">ECA,ISIS,NDAQ,SLE,SGP</category>
	</item>
	<item>
		<title><![CDATA[Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_19/ai_n28010733]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. & CARLSBAD, Calif. -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Molecular and Cellular Biology on the role of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/isis+pharmaceuticals+inc..html"><![CDATA[Isis Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ALNY,ISIS,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Alnylam Awarded Continued Funding Under U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_6/ai_n27971532]]></link>
		<description><![CDATA[Commitment for Continued Funding of $7.5 Million Supports Alnylam Biodefense[TM] Efforts and Broad Technology Development  CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that the National Institute of Allergy and Infectious Diseases NIAID, a component of the National Institutes of Health NIH,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 06 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/bioterrorism.html"><![CDATA[bioterrorism]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+government.html"><![CDATA[U.S. Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="tickers">ALNY</category>
	</item>
	<item>
		<title><![CDATA[Regulus Therapeutics Selected for Fierce 15 Top Biotech Companies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_24/ai_n27505723]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. & CARLSBAD, Calif. -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA miRNA therapeutics, announced today that it has been named to the annual FierceBiotech "Fierce 15" list, designating it as...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fiercebiotech.html"><![CDATA[FierceBiotech]]></category>
		<category domain="http://resources.bnet.com/topic/isis+pharmaceuticals+inc..html"><![CDATA[Isis Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ALNY,ISIS,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[We may all be space aliens: study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200806/ai_n26680302]]></link>
		<description><![CDATA[PARIS AFP &#8212; Genetic material from outer space found in a meteorite in Australia may well have played a key role in the origin of life on Earth, according to a study to be published Sunday.  European and US scientists have proved for the first time that two bits...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 13 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/earth.html"><![CDATA[Earth]]></category>
		<category domain="http://resources.bnet.com/topic/molecule.html"><![CDATA[molecule]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/scientist.html"><![CDATA[scientist]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_7/ai_n25385836]]></link>
		<description><![CDATA[CARLSBAD, Calif. & BELTSVILLE, Md. -- In research demonstrating that RNA previously thought to have no biological relevance may be of use for therapeutic and diagnostic targets, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and BioServe, the leading provider of clinically annotated...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/invitrogen+corp..html"><![CDATA[Invitrogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVGN</category>
		<category domain="tickers">IVGN</category>
	</item>
	<item>
		<title><![CDATA[The ABCs of molecular genetics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m1189/is_3_280/ai_n25427563]]></link>
		<description><![CDATA[Dear Dr. SerVaas,  I consider myself an educated reader, but I have forgotten the basics about genes and how RNA differs from DNA, Could you address this in basic language?  Donald Ray  Indianapolis, Indiana  Molecular biologists explain it this way: DNA makes RNA, RNA makes protein,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/abc+inc..html"><![CDATA[ABC Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[protein]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Roche Applied Science Selects the Technology of NuGEN WT-Ovation&#153; as RNA Amplification Product for LightCyclerŽ System]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_3/ai_n25123473]]></link>
		<description><![CDATA[Allows researchers to assess small samples in high throughput qPCR]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New Technique Involving Roche's LightCyclerŽ 480 Instrument Enables Efficient and Economic Studies on RNA Editing]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_4/ai_n24361713]]></link>
		<description><![CDATA[PENZBERG, Germany -- Current research in the area of RNA editing is limited by the lack of cheap, effective approaches for screening for new editing sites or for mutants affected in the editing process. Previously used methods to study RNA editing, such as cDNA sequencing, primer extension or pyrosequencing are...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 04 Mar 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/technique.html"><![CDATA[technique]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Intradigm Strengthens RNA Interference (RNAi) Position with MIT License.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200802/ai_n25822653]]></link>
		<description><![CDATA[Intradigm Corporation (Palo Alto, CA), a leading developer of  targeted, systemic RNA interference RNAi therapeutics, announced that  it has licensed a key patent related to nucleic acid delivery  technologies in the field of RNAi drug development from Massachusetts  Institute of Technology (Cambridge, MA). The licensing of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/massachusetts+institute+of+technology.html"><![CDATA[Massachusetts Institute of Technology]]></category>
		<category domain="http://resources.bnet.com/topic/polymer.html"><![CDATA[polymer]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Synamatix will collaborate with the Emory University School of Medicine]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6656/is_20_16/ai_n29444434]]></link>
		<description><![CDATA[Synamatix will collaborate with the Emory University School of Medicine to analyze small RNAs generated from mouse brain cognitive disease studies.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 31 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/emory+university.html"><![CDATA[Emory University]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mice.html"><![CDATA[Mice]]></category>
		<category domain="http://resources.bnet.com/topic/mouse.html"><![CDATA[mouse]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[RealPennies.com: Turning Pennies into dollars: (OTC BB:EWIN), (Nasdaq: GNTA), (OTC BB:EFSF) , (NASDAQ: RIMM), (NASDAQ: INTC).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25241950]]></link>
		<description><![CDATA[M2 PRESSWIRE-18 January 2008-RealPennies.com: RealPennies.com:  Turning Pennies into dollars: (OTC BB:EWIN), (Nasdaq: GNTA), (OTC  BB:EFSF) , (NASDAQ: RIMM), (NASDAQ: INTC).C1994-2008 M2 COMMUNICATIONS  LTD     RDATE:18012008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559  ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 18 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/efoodsafety.com+inc..html"><![CDATA[eFoodSafety.com Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/games.html"><![CDATA[Games]]></category>
		<category domain="http://resources.bnet.com/topic/intel+corp..html"><![CDATA[Intel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EFSF</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">EFSF,INTC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[News For The Morning.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25242132]]></link>
		<description><![CDATA[M2 PRESSWIRE-18 January 2008-Stock Profiler.US: News For The  MorningC1994-2008 M2 COMMUNICATIONS LTD     RDATE:18012008     New York, NY -- StockProfilers' "Stock News" For  this Friday:     Planar Systems, Inc. (NASDAQ: PLNR); Metavante Technologies, Inc.  (NYSE: MV); Kintera Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 18 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/invitrogen+corp..html"><![CDATA[Invitrogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/kintera+inc..html"><![CDATA[Kintera Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/metavante+corp..html"><![CDATA[Metavante Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/yahoo%2521+inc..html"><![CDATA[Yahoo! Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KNTA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">YHOO</category>
		<category domain="tickers">IVGN,KNTA,NDAQ,YHOO</category>
	</item>
	<item>
		<title><![CDATA[Speak with other shareholders about: (NASDAQ: PLNR), (NYSE: MV), (NASDAQ: KNTA), (Nasdaq: YHOO), (Nasdaq: SMTC), (NASDAQ: IVGN).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25242155]]></link>
		<description><![CDATA[M2 PRESSWIRE-18 January 2008-Stockwire.com: Speak with other  shareholders about: (NASDAQ: PLNR), (NYSE: MV), (NASDAQ: KNTA), (Nasdaq:  YHOO), (Nasdaq: SMTC), (NASDAQ: IVGN)C1994-2008 M2 COMMUNICATIONS LTD     RDATE:18012008     AUSTIN, TX -- Are you looking to speak with other investors about  your favorite...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 18 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/invitrogen+corp..html"><![CDATA[Invitrogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/kintera+inc..html"><![CDATA[Kintera Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/metavante+corp..html"><![CDATA[Metavante Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/yahoo%2521+inc..html"><![CDATA[Yahoo! Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KNTA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">YHOO</category>
		<category domain="tickers">IVGN,KNTA,NDAQ,YHOO</category>
	</item>
	<item>
		<title><![CDATA[EWIN Ready To Launch Online Gaming Platform In China.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25241687]]></link>
		<description><![CDATA[M2 PRESSWIRE-17 January 2008-AnalystResearchReport.com: EWIN Ready  To Launch Online Gaming Platform In ChinaC1994-2008 M2 COMMUNICATIONS  LTD     RDATE:17012008     Stocks to Watch: eWorld Interactive, Inc. (OTC BB:EWIN),Genta  Incorporated (Nasdaq: GNTA), eFoodSafety.com (OTC BB:EFSF) , Obopay,  Inc. (NASDAQ: RIMM) Intel Corporation...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 17 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/efoodsafety.com+inc..html"><![CDATA[eFoodSafety.com Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/games.html"><![CDATA[Games]]></category>
		<category domain="http://resources.bnet.com/topic/intel+corp..html"><![CDATA[Intel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EFSF</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">EFSF,INTC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Invitrogen Enters Non-Coding RNA Licensing Agreement with IMBcom]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_17/ai_n24232612]]></link>
		<description><![CDATA[Deal to Broaden Invitrogen's Offerings for Epigenetic Analysis]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 17 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/invitrogen+corp..html"><![CDATA[Invitrogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVGN</category>
		<category domain="tickers">IVGN</category>
	</item>
	<item>
		<title><![CDATA[Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200801/ai_n21919874]]></link>
		<description><![CDATA[To: NATIONAL EDITORS Contact: Media: Holly Barkhymer, +1-212-509-0995 x242, hbarkhymer@michaeljfox.org, or Research: Todd Sherer, PhD, +1-212- 509-0995 x243, tsherer@michaeljfox.org  NEW YORK,Jan. 4/PRNewswire-USNewswire/ --The Michael J. Fox Foundation has committed up to $3.8 million for the development of a gene silencing therapeutic to treat Parkinsons disease by reducing expression of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/gene.html"><![CDATA[gene]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Nastech Receives Notice of Allowance for United States Patent Related to Methods for Identifying Cell-Specific Targeting Peptides.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200801/ai_n25822697]]></link>
		<description><![CDATA[Nastech Pharmaceutical Company, Inc. (Bothell, WA) announced that  the United States Patent and Trademark Office USPTO has issued a  Notice of Allowance for United States patent application 10/976,942,  entitled "Phage Displayed Trp Cage Ligands." The patent  application has claims that relate to a novel, high-throughput method...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[protein]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
